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Abstract
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Immunization with radiation-attenuated sporozoites (RAS) via mosquito bites has been shown to
induce sterile immunity against malaria in humans, but this route of vaccination is neither practical
nor ethical. The importance of delivering RAS to the liver through circulation in eliciting
immunity against this parasite has been recently verified by human studies showing that high-level
protection was achieved only by intravenous (IV) administration of RAS, but not by intradermal
(ID) or subcutaneous (SC) vaccination. Here, we report in a murine model that ID inoculation of
RAS into laser-illuminated skin confers immune protection against malarial infection almost as
effectively as IV immunization. Brief illumination of the inoculation site with a low power 532
nm Nd:YAG laser enhanced the permeability of the capillary beneath the skin, owing to
hemoglobin-specific absorbance of the light. The increased blood vessel permeability appeared to
facilitate an association of RAS with blood vessel walls by an as-yet-unknown mechanism,
ultimately promoting a 7-fold increase in RAS entering circulation and reaching the liver over ID
administration. Accordingly, ID immunization of RAS at a laser-treated site stimulated much
stronger sporozoite-specific antibody and CD8+IFN-γ+ T cell responses than ID vaccination and
provided nearly full protection against malarial infection, whereas ID immunization alone was
ineffective. This novel, safe, and convenient strategy to augment efficacy of ID sporozoite-based
vaccines warrants further investigation in big animals and in humans.
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Introduction
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Malaria is a tropical disease mainly caused by plasmodium falciparum parasites and
transmitted by infected mosquitoes. The WHO estimated that there were 207 million
malarial infection cases and 627,000 related deaths in 2012 alone [1]. Effective vaccines
would be the best strategy to control malarial epidemics if available, but currently the most
advanced subunit malaria vaccine, RTS, S, can only provide about 50% protection in
humans [2]. Another promising whole-parasite malaria vaccine, comprised of radiationattenuated plasmodium falciparum sporozoites (PfSPZ), confers >80% protection in human
volunteers [3]. All 6 volunteers who received 5 doses of intravenous (IV)-injected
sporozoites and 6 out of 9 volunteers who received 4 doses were protected from malaria
infection [3]. By traveling through circulation, radiation-attenuated sporozoites (RAS) reach
the liver, infect hepatocytes, the only cells susceptible to malarial infection, and synthesize
liver stage-specific antigens. These newly synthesized antigens, along with RAS, are major
determinants for stimulating a protective immunity against malaria infection [4]. The ability
of RAS to elicit immunity against sporozoites and liver-stage parasite partially explains why
the whole-organism vaccine PfSPZ is more effective than RTS, S vaccine that consists of a
single protein. Conceivably, for sporozoite-based vaccines, the greater amounts of RAS are
loaded to the liver and the stronger the immunity could be induced. Although IV injection is
an efficient route for delivering sporozoites to the liver, it faces formidable technical hurdles
in vaccination of a large population. On the other hand, intradermal (ID) vaccination is a
more clinically acceptable route and mimics natural infection. Yet, ID vaccination is far less
efficient than IV immunization, probably because entrance of sporozoites into blood and
lymphatic vessels is highly restricted in the dermis [5], especially for cryopreserved RAS
that show reduced motility.
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It remains unclear why RAS inoculated by mosquito bites can induce sterile immunity,
whereas ID inoculation is less effective [6]. While it seemed plausible that mosquito bites
directly inoculated RAS into blood vessels, resembling IV injections, recent studies found
this was not the case because mosquitoes inoculated the majority of SPZs into the
extravascular region of the dermis rather than directly into the vasculature [7–10]. The
observation hardly explains the suboptimal immune responses and poor protection induced
by ID or subcutaneous (SC) injection in clinical trials [11]. Similar results were also found
in rodent models, in which immunization with cryopreserved RAS by IV injection provided
90–100% protection, whereas immunizations via other routes such as ID, SC or
intramuscular (IM) were far less effective [11–13] because fewer sporozoites reached the
liver by these routes of immunization. To achieve a similar level of protection, a
substantially higher number of sporozoites are required for ID or SC immunization [11, 13].
Unfortunately, dissection of sporozoites from infected mosquitoes is time-consuming,
tedious, and cost-ineffective. Simply increasing the number of RAS per dose would increase
the cost considerably, which would be problematic for a prophylactic vaccine needed by a
large population in underdeveloped countries.
It is possible that ID injection of RAS by a syringe doesn’t perform as mosquito bites,
because when a mosquito probes blood, its proboscis damages the blood vessel. Sporozoites
can then enter the blood vessel [14] in a process that may not be recapitulated by ID
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injection. For more than a decade, lasers have been used to treat vascular malformations in
the clinics on the basis of “selective photothermolysis” [15]. Hemoglobin and
oxyhemoglobin inside red blood cells have peak of light absorbance from 540 nm to 578 nm
[16]. Thus, upon laser illumination near these wavelengths, abundant hemoglobin and
oxyhemoglobin flowing inside blood vessels absorb laser energy and convert into heat to
destroy malformed capillaries in human skin [17]. Since laser energy can be well controlled
by energy density, laser power, pulse, and duration of illumination, we postulate that laser at
a much lower energy density can slightly injure capillary vessels and promote entrance of
sporozoites into blood vessels, simulating the process of mosquitoes’ blood probing.

Author Manuscript

In the present study, different laser parameters are tested to selectively injure capillaries at
the inoculation site. We found that a 532 nm laser at 1 J / cm2 could increase permeability of
the blood vessel and skin-to-liver delivery of ID-injected sporozoites significantly. Increased
permeability of blood vessels appeared to facilitate an association of sporozoites with blood
vessel walls via a yet unknown mechanism. The laser-mediated enhancement of skin-toliver delivery of RAS resulted in much stronger sporozoite-specific immune responses than
ID vaccination alone and conferred protection against malarial infection nearly as effectively
as IV immunization.

Materials and Methods
Animals and parasites

Author Manuscript

Female BALB/c mice at 8 weeks of age were purchased from Charles River Laboratory.
Mosquitoes carrying Plasmodium yoelii-GFP (PyGFP) sporozoites were provided by
Insectary Core Facility of Langone Medical Center, New York University. Fresh fluorescent
sporozoites were isolated by dissecting mosquitoes under stereomicroscopy. Purified,
aseptic, irradiated or non-irradiated P. yoelii sporozoites were preserved in the vapor phase
of liquid nitrogen and provided by Sanaria (Maryland, USA). Animal protocols were
approved by the Institutional Animal Care and Use Committee (IACUC) of Massachusetts
General Hospital.
Selective blood vessel injury by lasers

Author Manuscript

A 532 nm Nd:YAG laser (Spectra-Physics Inc., Mountain View, CA) and a 595 nm pulsed
dye laser (Vbeam, Candela, MA) were used in this study (Table 1). To test the effects of
lasers on the permeability of capillaries beneath the skin, FITC-conjugated dextran (MW
200,000) was injected into the tail vein to label blood vessels of mice, and the dorsal skin
was then illuminated by lasers at different settings. Leakage of FITC-dextran in laser-treated
skin was examined by intravital confocal microscopy (Olympus). Alternatively, the skin was
treated with laser, followed by FITC-dextran injection and microscopic analysis to
determine duration of the leakage. For histological examination, laser-treated skin was
collected immediately after laser treatment, fixed in 10% formalin, and processed by
standard hematoxylin and eosin (H&E) staining. Slides were analyzed by Nanozoomer Slide
Scanner (Hamamatsu).
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Confocal microscopy of ID-injected sporozoites
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Texas red-conjugated dextran (MW 70,000) was injected intravenously to label blood
vessels. P. yoelii sporozoites were stained with carboxyfluorescein succinimidyl ester
(CFSE) for 5 min, washed twice by PBS, and resuspended in PBS. The stained sporozoites
at a concentration of 5,000 sporozoites in 0.5 μl PBS were administered into mouse ears
after illumination with 532 nm laser or sham light by a micro-liter syringe (Hamilton
1701N). The ears were harvested 15 minutes after the injection, fixed in 10% formalin, and
examined under a confocal microscope (Olympus).
Quantification of parasite loads in the liver
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To quantify parasite loads in the liver, mice were IV administered with varying numbers of
sporozoites, and the liver was harvested 42 hr later. Total RNA was extracted from an
aliquot of the liver cells. Parasite-specific 18S rRNA was reverse transcribed and amplified
by real-time PCR (the Roche SYBR Green system) or RT-qPCR with primers: forward, 5′GGGGATTGGTTTTGACGTTTTTGCG-3′ and reverse, 5′AAGCATTAAATAAAGCGAATACATCCTTAT-3′ [18, 19]. The housekeeping gene βactin was used as an internal control using primers: forward, 5′CTGGGACGACATGGAGAAGATC-3′ and reverse, 5′GTCTCAAACATGATCTGGGTCATC-3′. The effect of laser on parasite loads in the liver
was assessed by equivalency to the number of parasites in the liver after varying numbers of
RAS were IV injected. For PyGFP sporozoites, equal amounts of freshly isolated PyGFP
sporozoites were administered via IV or ID at laser-treated or sham-treated sites. Livers
were harvested 42 hours later and dissociated to prepare single cell suspension by a 70 μm
cell strainer. Aliquots of liver cells were either extracted to obtain total RNA or analyzed by
flow cytometry to count GFP+ cells in the liver.
Immunization and challenge
Irradiated 2,000 P. yoelii sporozoites were either IV injected into the tail vein or ID injected
into laser-treated or untreated dorsal skin. The immunization was repeated twice with 2week intervals. Mice were challenged by IV injection of 200 non-irradiated P. yoelii
sporozoites 7 days after the last immunization. Blood samples were collected for thin blood
smears analyzing percent parasitemia from days 3 to 21 post-challenge after Giemsa staining
under a Zeiss Axiophot microscope.
Immunofluorescence assay of sporozoite-specific antibody

Author Manuscript

Sporozoite-specific antibody titer was measured by immunofluorescence assay 7 days after
the final immunization as described [11]. Briefly, 2,000 sporozoites in 20 μl PBS containing
2% bovine serum albumin (BSA) were coated to each well of Cel-Line slides (Thermo
Scientific) and air dried. Pre-immune sera were diluted at 1:50, while immune sera were
serially diluted starting from 1:50. The slide was incubated with 20 μl diluted pre-immune
and immune sera at 37 °C for 1 hour in a moisture box. After washing three times in PBS,
slides were incubated with FITC-conjugated rabbit anti-mouse IgG antibody for 1 hour.
After wash, vectashield mounting medium (Vector laboratories) was added to each well
before placing a cover glass to the slide. The slides were examined under an Olympus BX51
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fluorescence microscope at 400 × magnification. Fluorescence intensity in each well was
recorded and measured by ImageJ. The endpoint titer was defined as the highest dilution of
immunized sera that had higher fluorescence intensity than the pre-immune sera.
Measurement of sporozoite-specific T cell responses
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Mice were immunized three times each with 10, 000 sporozoites administered by IV or ID
in the presence or absence of laser illumination as detailed above. The mice were sacrificed
7 days after the final immunization and the liver, spleen, and blood were collected. The liver
and spleen were dissociated by a 70 μm cell strainer. The cell suspensions, along with blood
samples, were treated with Ammonium-Chloride-Potassium lysing buffer to remove red
blood cells, and lymphocytes were isolated using Percoll (33%) as described [20].
Lymphocytes were then stimulated with 1mg / ml PyCSP280-288 peptide (SYVPSAEQI)
for 21 hours at 37 °C with 1 μg / ml Golgin-plug in the culture for the final 5 hr. The
stimulated cells were harvested, fixed with 2% formaldehyde, permeabilized with
permeabilization buffer (eBioscience), and stained with indicated antibodies. Among the
antibodies used, PerCP-Cy5.5 anti-Mouse CD8α antibody (clone 53–6.7) was purchased
from eBioscience, PE anti-mouse CD11a Antibody (M17/4), Alexa 647 anti-mouse CD90.2
(30-H12) antibody, and FITC anti-mouse IFN-γ antibody (XMG1.2) from Biolegend, antimouse CD16/CD32 antibody (2.4G2) from BD Biosciences. The stained cells were assessed
on FACSAria (BD Biosciences) and analyzed by FlowJo software (version 7.6.5).
Statistics

Author Manuscript

One-way ANOVA followed by Tukey’s multiple comparison tests were used to analyze the
differences among multiple groups. Two-way ANOVA followed by Bonferroni post tests
were used to analyze the parasitemia and compare the differences among selected groups.
Log-rank test was used to analyze the survival data. All statistical analyses were performed
using Prism GraphPad 6.

Results
Laser illumination alters the permeability of capillaries in the skin

Author Manuscript

To mimic mosquito bites, laser was used to target blood vessels in the skin. Previous studies
have shown that lasers at 540 nm and 578 nm could induce selective blood vessel injury [15,
17]. We thus chose a 532 nm laser and a 595 nm laser for initial tests. Mice were IV injected
with vessel-impermeable FITC-dextran to label the capillary network (Fig. 1A). After 532
nm laser treatment at a low dose of 1 J / cm2, some dye leaked out and scattered over the
laser-treated skin. Capillary vessels appeared to enlarge slightly compared with those in
untreated skin (Figure 1A, panel 1 vs 2). Slight enlargement of capillary vessels was
corroborated by histological examination and notably, there was no leakage of red blood
cells out of the vessel in spite of the enlargement (Fig. 1C, arrow). The surrounding tissue of
the dilated vessel was also normal (Figure 1B and C). As expected, the 532 nm laser at a
higher dose of 9 J / cm2 (total energy of 3.46 J) led to more FITC-dextran leakage,
concomitant with vessel injuries or rupture as evidenced by leakages of red blood cells from
the vessel (Figure 1C). Treatment with the 595 nm laser at 5 J / cm2 or 20 J / cm2 resulted in
robust leakage of FITC-dextran (Fig. 1A), as well as vessel rupture, respectively (Fig. 1C).
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Laser promotes delivery of ID-injected sporozoites to the liver
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We next investigated whether the laser could promote delivery of ID-injected sporozoites to
the liver. Since RAS did not replicate in the liver [21] and could not be detected by RTqPCR (data not shown), we used non-irradiated sporozoites instead. The amount of
sporozoites that reached the liver after ID injection was calculated based on a standard curve
generated by IV injection of varying numbers of sporozoites (Fig. 2A). As shown in Fig. 2B,
ID injection of 4,000 sporozoites resulted in a parasite load that was equal to IV injection of
about 400 sporozoites, suggesting that only 10% sporozoites entered blood circulation after
ID inoculation. In contrast, illumination of the skin with 532 nm laser at 1 J/cm2 gave rise to
parasite liver loads equivalent to IV injection of about 2,800 sporozoites (Figure 2B),
indicative of a 7-fold increase over ID inoculation alone. To our surprise, a high dose of
laser at 9 J / cm2 enhanced liver-delivery of sporozoites by only 4-fold. The less efficiency
of laser at a higher dose hinted that severe blood vessel damage might reduce a skin-to-liver
delivery of sporozoites. Although the underlying mechanism was unknown, a continuous
flow of the bloodstream at the inoculation site might be crucial for sporozoites trafficking to
the liver. Too much capillary damage by 595 nm laser may adversely affect traveling of
sporozoites from the skin to the liver. Another possibility was that coagulation of red blood
cells inhibited the motility of sporozoites as shown by previous investigation [10].
Consistent with this, the 595 nm laser did not enhance sporozoite delivery to the liver as
effectively as 532 nm laser. Illumination with 595 nm laser for 5 J / cm2 only increased the
delivery by 2-fold and no significant increase was seen with 20 J / cm2. Accordingly, the
532 nm laser at 1 J / cm2 was used in subsequent studies.
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We next corroborated the effects of laser skin treatment on the trafficking of freshly isolated
PyGFP sporozoites after ID administration [22] since cryopreserved sporozoites used in the
preceding experiment might have a low vitality and infectivity. As shown in Fig. 2C, the
percentage of GFP+ cells in the liver was significantly higher in the presence of laser
treatment than in the absence of the treatment. Liver parasite loads were also much higher in
Laser+ID group than in ID group (Fig. 2D). These results suggest that laser could enhance
skin-to-liver delivery of sporozoites whether the sporozoites are freshly isolated or
cryopreserved.

Author Manuscript

To determine how laser treatment of the skin could facilitate delivery of ID-injected
sporozoites to the liver, sporozoites were fluorescently labeled and injected into laser-treated
or untreated skin, followed by confocal microscopic analysis. After ID injection, most
sporozoites were randomly scattered in the skin, and only a few sporozoites were close to
blood vessel walls in the absence of laser treatment (Fig. 3B). In contrast, many sporozoites
bound tightly to blood vessel walls and some entered the vessels in laser-treated skin (Fig.
3C). The percentage of sporozoites that were associated with or inside blood vessels was
significantly higher in Laser+ID group than in ID group (Fig. 3D). The observations suggest
that laser treatment of the skin facilitated sporozoites moving towards and binding to blood
vessels. Increased association of sporozoites with blood vessels was consistent with their
efficient entrance of the bloodstream.
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Laser enhances the immune responses provoked by ID immunization of sporozoites
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Laser-mediated enhancement in delivery of ID-injected sporozoites to the liver should
translate into stronger immune responses. To verify this, the lower dorsal skin of mice was
illuminated by laser, followed by ID inoculation of 10,000 RAS, while control mice
received either IV or ID injection of an equal amount of RAS. After three immunizations,
sporozoite-specific antibody titer was measured by immunofluorescence assays. As shown
in Fig. 4A, anti-sporozoite antibody titer was substantially higher in laser+ID group than in
the ID group, although it was lower than that in the IV group. Likewise, CD8+ IFN-γ+ T
cells in peripheral blood mononuclear cells (PBMCs) in Laser+ID group were significantly
higher than those in ID group. The level of CD8+ IFN-γ+ T cells was comparable to that in
IV group (Fig. 4B).
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It has been reported that protection against malarial infection depends on sporozoite-specific
CD8+ T cells producing IFN-γ in the liver [23–26]. When naive CD8+ T cells encountered
sporozoites, the cells expressed a reduced level of CD8α while increasing CD11a on the cell
surface [27, 28]. Thus, percentages of CD11ahi CD8αlo cells were analyzed in the liver and
spleen and these cells were found to be significantly higher in the presence of laser treatment
than in the absence of the treatment (Fig. 5A and 5B). Moreover, upon stimulation with a
sporozoite T cell epitope peptide derived from the circumsporozoite protein (CSP280–288,
SYVPSAEQI), significantly higher percentages of cells secreting IFN-γ were attained in
Laser+ID group than in the ID group and in both liver and spleen, confirming that Laser+ID
immunization induced stronger immune responses than ID immunization alone (Fig. 5C).
Laser plus ID immunization offers a high level of protection against malarial challenge
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A challenge study was next carried out to determine the efficacy of laser plus ID
vaccination. Mice were immunized three times each with 2,000 RAS and challenged by IV
injection of 200 infectious sporozoites 7 days after the last immunization. Blood parasitemia
revealed that 7 out of 8 mice in Laser+ID group were protected, whereas all animals in ID
group were infected (Table 2). The protection rate of Laser+ID group was 87.5%, which was
comparable to that of IV group, and significantly higher than the ID group (p<0.001).
Percent parasitemia in Laser+ID group was significantly lower than that of ID group (Fig.
6A). This result was also verified by RT-qPCR analysis of blood parasite loads (Fig. 6B).

Discussion
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Our present study shows that a brief illumination of the inoculation site by a low power laser
followed by ID inoculation of RAS confers much stronger protection against malarial
challenge than ID immunization alone. The protection was comparable to IV immunization
and was associated with an increase in the number of irradiated sporozoites trafficking to the
liver. In the absence of laser treatment, only 10% of sporozoites entered the blood vessels
following ID injection (Fig. 2A), which was similar to previous studies showing that ID
inoculation of p. yoelii sporozoites gave rise to liver parasite burden at a level 10- to 20-fold
lower than IV inoculation [29]. This held truth for p. berghei-GFP-Luc sporozoites as well
[30]. Accordingly, 7–10 times more sporozoites were required by ID immunization to
achieve the same level of protection by IV vaccination [11]. Whereas the IV injection route
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is cumbersome, especially when it is performed in infants and young children, the high
number of RAS required for effective ID immunization alone greatly increases the cost of
the vaccine. In this regard, human studies showed that at least 5 doses of PfSPZ vaccine
each at 1.35 × 105 sporozoites or a total of 6.75 × 105 PfSPZ were needed to confer a full
protection in a single person [3]. Considering that a six-person dissection team can dissect
only 500 mosquitoes per hour and one mosquito contains 2 × 104 PfSPZ, it costs 4~5
working hrs of a skilled technician to dissect a sufficient number of RAS for one vaccinee
[31]. By illumination of a tiny area of the skin, the number of RAS for effective ID
immunization can be reduced by 7-fold in the basis of our investigation, leading to great cost
savings. In the future, a small, handheld device can be fabricated incorporating laser
illumination and a convenient ID injection device, like microneedles, for efficient and
convenient delivery of RAS vaccines if the efficacy of laser-assisted ID immunization is
confirmed in humans.
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Amino et al. estimated that about 35% sporozoites inoculated by mosquitoes entered blood
vessels in the skin [8], which was much higher than the 10% of cryopreserved sporozoites
ID injected (Figure 2D). The low efficiency of ID-injected sporozoites across blood vessels
may be caused by blunted motility of sporozoites after cryopreservation, as movement of
these sporozoites was hardly detected under a confocal microscope in the skin. Vessel
damages caused by mosquito bites may facilitate entrance of sporozoites into the
bloodstream. To mimic mosquito bites, we used a laser to induce blood vessel injury and
found that illumination of the skin with a 532 nm laser at 1 J/cm2 enhanced vessel
permeability without causing significant damages to the vessel structure. Increased blood
vessel permeability, rather than severe blood vessel damage, was sufficient in facilitation of
sporozoite travel from the skin to the liver. The efficiency was even greater than that of
mosquito bites. Laser with a higher energy induced more severe vessel damages but failed to
promote a skin-to-liver trafficking of sporozoites as efficiently as a low energy laser.
Perhaps rupture of blood vessels and coagulation of red blood cells hindered the motility of
the sporozoites, in agreement with an earlier study suggesting that the motility of
sporozoites in hematoma-coagulation of red blood cells was greatly inhibited via an
unknown mechanism [10]. Thus, it will be critical to avoid severe vessel rupture and
hematomas with laser-assistance of ID immunization of sporozoites.
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It remains unclear how sporozoites, after being inoculated into the skin, can navigate to
capillary vessels and enter the bloodstream. One study suggests that sporozoites move
randomly in the dermis until they happen to contact a blood vessel, then move along the
vessel and penetrate across the vessel wall [8]. Under this assumption, sporozoites
encountering a lymphatic vessel instead of a blood vessel would enter the lymphatic system
[8, 32]. Another possibility is that sporozoites are stimulated or guided toward a blood
vessel. Vanderberg et al. demonstrated in vitro that serum albumin could significantly
stimulate the motility of sporozoites [33, 34]. Similarly, Hellmann et al. postulated that
environmental constraints directed the movement of sporozoites, although the nature of the
environmental constraints remains uncharacterized [35]. Our current investigation suggests a
random movement of sporozoites in the skin after ID administration and only a few
sporozoites are located close to a blood vessel in the control skin (Fig. 3B). However, in
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laser-treated skin, substantially more sporozoites were found binding tightly to a vessel wall
or inside a vessel (Fig. 3C). Because laser treatment enhances the permeability of blood
vessels, it is possible that albumin leakage stimulated sporozoites to move toward and stick
on a vessel wall in a manner similar to chemotaxis, although further investigation is required
to conclude this.

Author Manuscript

CD8+ T cells and IFN-γ production in the liver are found to be essential for malarial
protection [23–26]. Laser illumination followed by ID immunization induced a higher level
of CD11ahi CD8αlo cells secreting IFN-γ than the ID group, in both liver and spleen (Fig.
5), in agreement with increased trafficking of sporozoites to the liver. This translated to
protection against malaria challenge at a level comparable to IV immunization. Recent
human studies clearly showed that a high level protection occurred only in volunteers IV but
not ID or SC immunized [3, 11]. The ability of laser to augment ID immunization almost as
effectively as IV immunization warrants further investigation of the novel approach in big
animals and humans.
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Figure 1.

Laser illumination enhances blood vessel permeability. (A) Representative images showing
blood vessel leakage induced by laser. Blood vessels were marked by FITC-dextran IV
injected, after which the dorsal skin of the mice was treated by different lasers and examined
under an intravital confocal microscope within 30 min. (B) Representative histological
examination of laser-treated skins. (C) Alterations of blood vessels induced by lasers.
Bar=100 μm in A and B or 10 μm in C. Arrows indicate blood vessels. n=5.
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Figure 2.
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Laser enhances the delivery of sporozoites from the skin to liver. (A) A standard curve of
liver parasite loads after IV injection of indicated numbers of sporozoites. (B) Effects of
laser skin illumination on skin-to-liver delivery of sporozoites. Mice were injected with
4,000 sporozoites either by an IV route or through ID injection into laser-treated or untreated dorsal skin (ID). The liver parasite loads were determined by RT-qPCR and
estimated using the standard curve 2A. (C and D). GFP+ cells were measured by flow
cytometry 42 hrs after freshly isolated PyGFP sporozoites were injected by IV or ID in the
presence or absence of laser treatment (C). Liver parasite loads were quantified by RTqPCR in the animals (D). Results are expressed as means ± standard deviation (SD). The
experiment was repeated twice with similar results. n=8, *p<0.05, **p<0.01, ***p<0.001,
and ns, not significant.
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Figure 3.
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Confocal microscopy of sporozoites in the skin. (A) Blood vessels were marked by Texas
red-dextran (MW 70,000). (B and C) Representative images of CFSE-stained sporozoites in
un-treated (B) or laser-treated skin (C). Bar =10 μm. (D) Percentages of sporozoites in
association with vessel walls or inside the vessels. Data are shown as means ± SD. n=10,
***p<0.001.
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Figure 4.
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Peripheral immune responses against sporozoites. Mice were immunized with three doses of
RAS each with 10,000 sporozoites at an interval of two weeks. Geometric mean titers
(GMT) of anti-sporozoite antibody were determined by immunofluorescence assay (A) and
CD8+ T cells in PBMCs were analyzed by flow cytometry (B) 7 days after the final
immunization. The results are expressed as means ± SD. N=8, *p<0.05, **p<0.01, and
***p<0.001.
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Figure 5.
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Frequencies of sporozoite-specific CD8+ T cells in the liver and spleen. Mice were
immunized with three doses of RAS each with 10,000 sporozoites at an interval of two
weeks. Representative flow profiles of sporozoite-experienced CD11ahi CD8αlo cells in the
liver and spleen are shown in (A). Mean frequencies ± SD of CD11ahi CD8αlo cells (B) and
IFN-γ+-producing CD8+ T cells (C) were attained in the liver and spleen by flow cytometry
7 days after the final immunization. n=8, **p<0.01, ***p<0.001 and ns, not significant.
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Figure 6.
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Protection against malarial challenge. Mice were immunized with three doses of RAS each
with 2,000 sporozoites at an interval of two weeks. All animals were challenged by IV
injection of 200 live P. yoelii sporozoites 7 days after the final immunization. Parasitemia
were monitored at indicated days post-challenge by blood smear (A) and blood parasite
burdens were determined by RT-qPCR on day 10 post challenge (B). The results are
expressed as Mean ± SD. n=8, **p<0.01 and ***p<0.001 between ID and Laser+ID group
in A or ***p<0.001 and ns, not significant in B.
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Wavelength
532 nm
532 nm
595 nm
595 nm

1

2

3

4

0.45 ms

0.45 ms

5–7 ns

5–7 ns

Pulsewidth

7 mm

7 mm

7 mm

7 mm

Beam Diameter
0.38 J
3.46 J
1.92 J
7.69 J

J/cm2
J/cm2

5 J/cm2
J/cm2

20

9

1

Energy

Fluence
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Laser Conditions
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Laser parameters used in the study.
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Result of the challenge study.
Immunization route

Infected/Injected

Protection

Un-immunized

8/8

0

IV

0/8

100%

ID

8/8

0

Laser+ID

1/8

87.5%***

***

p<0.001 compared with ID group.
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